Heart Transplant clinical trials at UCLA

4 in progress, 2 open to eligible people

Showing trials for

  • XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

    open to eligible people ages 18 years and up

    The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.

    Los Angeles, California and other locations

  • Non-invasive Prediction of EArly Cardiac rEjection

    open to eligible people ages 6-25

    Acute rejection remains a major cause of morbidity and mortality in pediatric patients after heart transplant. In order to screen for rejection, most centers perform heart catheterizations with endomyocardial biopsies frequently in the first year post transplant and then every 1-2 years thereafter; these biopsies are associated with complications, can cause significant anxiety in patients and family members, and are a significant cost for the healthcare system. This project will evaluate non-invasive methods of detecting rejection using cardiac magnetic resonance imaging and blood testing with a goal to reduce the required number of cardiac catheterizations.

    Los Angeles, California and other locations

  • XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.

    Los Angeles, California and other locations

  • Surveillance HeartCare® Outcomes Registry

    Sorry, in progress, not accepting new patients

    This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

    Los Angeles, California and other locations

Our lead scientists for Heart Transplant research studies include .

Last updated: